Two diabetes trials shed a little light on deaths
CHICAGO (Reuters) - Researchers who compared two diabetes trials said on Friday they are getting some insight into why patients in one were more likely to die after aggressive treatment, while patients in another were not.
<p><img src="http://feeds.reuters.com/~a/reuters/scienceNews?i=GzkxYp" border="0"></img> (http://feeds.reuters.com/~a/reuters/scienceNews?a=GzkxYp)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/scienceNews?i=1uJy9I" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=1uJy9I) <img src="http://feeds.reuters.com/~f/reuters/scienceNews?i=Y7qqgi" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=Y7qqgi) <img src="http://feeds.reuters.com/~f/reuters/scienceNews?i=BlhT2i" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=BlhT2i)
</div><img src="http://feeds.reuters.com/~r/reuters/scienceNews/~4/308153296" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/scienceNews/~3/308153296/idUSN0640739920080609